FDA Drug recall D-0358-2025
Haloperidol Decanoate Injection, 100 mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873…
- FDA Drug
- Class II
- ongoing
- Published 2025-04-16
On 2025-04-16 the FDA classified a Class II recall of Haloperidol Decanoate Injection, 100 mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873… by Somerset Therapeutics Private, citing lack of Assurance of Sterility: Media fill with bacterial contamination.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0358-2025 |
| Classification | Class II |
| Status | ongoing |
| Initiated | 2025-03-21 |
| Published | 2025-04-16 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Somerset Therapeutics Private |
| Distribution | US |
Product
Haloperidol Decanoate Injection, 100 mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-383-10
Reason
Lack of Assurance of Sterility: Media fill with bacterial contamination
Identifiers
| ndc | 70069-030-05 |
|---|---|
| ndc | 70069-030-03 |
| ndc | 70069-031-01 |
| ndc | 70069-031-05 |
| ndc | 70069-381-01 |
| ndc | 70069-381-10 |
| ndc | 70069-382-01 |
| ndc | 70069-382-05 |
| ndc | 70069-383-05 |
| ndc | 70069-383-10 |
| ndc | 70069-383-01 |
| ndc | 70069-384-01 |
| ndc | 70069-384-05 |
| code_info | A240482D, exp. date 08/2026 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0358-2025%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.